Semlopaline to prevent lethal and / or morbidity in patients undergoing major orthopedic surgery

摘要

The invention relates to the use of semuloparin or a pharmaceutically acceptable salt thereof for the prevention of a mortality and/or morbidity event, more specifically venous thromboembolism and death, in a patient undergoing major orthopaedic surgery, such as hip replacement, knee replacement or hip fracture surgery.